Revision as of 15:29, 26 November 2017 by en>JCW-CleanerBot(→Further reading: task, replaced: Frontiers in neuroendocrinology → Frontiers in Neuroendocrinology using AWB)
Corticotropin-releasing hormone is a potent stimulator of synthesis and secretion of preopiomelanocortin-derived peptides. Although CRH concentrations in the human peripheral circulation are normally low, they increase throughout pregnancy and fall rapidly after parturition. Maternal plasma CRH probably originates from the placenta. Human plasma contains a CRH-binding protein which inactivates CRH and which may prevent inappropriate pituitary-adrenal stimulation in pregnancy.[2]
References
↑Behan DP, Potter E, Lewis KA, Jenkins NA, Copeland N, Lowry PJ, Vale WW (Jun 1993). "Cloning and structure of the human corticotrophin releasing factor-binding protein gene (CRHBP)". Genomics. 16 (1): 63–8. doi:10.1006/geno.1993.1141. PMID8198617.
Behan DP, De Souza EB, Lowry PJ, et al. (1996). "Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides". Frontiers in Neuroendocrinology. 16 (4): 362–82. doi:10.1006/frne.1995.1013. PMID8557170.
Westphal NJ, Seasholtz AF (2006). "CRH-BP: the regulation and function of a phylogenetically conserved binding protein". Front. Biosci. 11: 1878–91. doi:10.2741/1931. PMID16368564.
Potter E, Behan DP, Fischer WH, et al. (1991). "Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins". Nature. 349 (6308): 423–6. doi:10.1038/349423a0. PMID1846945.
Behan DP, Linton EA, Lowry PJ (1989). "Isolation of the human plasma corticotrophin-releasing factor-binding protein". J. Endocrinol. 122 (1): 23–31. doi:10.1677/joe.0.1220023. PMID2549150.
Behan DP, Heinrichs SC, Troncoso JC, et al. (1995). "Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease". Nature. 378 (6554): 284–7. doi:10.1038/378284a0. PMID7477348.
Vamvakopoulos NC, Sioutopoulou TO, Durkin SA, et al. (1995). "Mapping the human corticotropin releasing hormone binding protein gene (CRHBP) to the long arm of chromosome 5 (5q11.2-q13.3)". Genomics. 25 (1): 325–7. doi:10.1016/0888-7543(95)80151-B. PMID7774945.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Fischer WH, Behan DP, Park M, et al. (1994). "Assignment of disulfide bonds in corticotropin-releasing factor-binding protein". J. Biol. Chem. 269 (6): 4313–6. PMID8307998.
Donaldson CJ, Sutton SW, Perrin MH, et al. (1996). "Cloning and characterization of human urocortin". Endocrinology. 137 (5): 2167–70. doi:10.1210/en.137.5.2167. PMID8612563.
Asakura H, Zwain IH, Yen SS (1997). "Expression of genes encoding corticotropin-releasing factor (CRF), type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary". J. Clin. Endocrinol. Metab. 82 (8): 2720–5. doi:10.1210/jc.82.8.2720. PMID9253360.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Wetzka B, Sehringer B, Schäfer WR, et al. (2004). "Expression patterns of CRH, CRH receptors, and CRH binding protein in human gestational tissue at term". Exp. Clin. Endocrinol. Diabetes. 111 (3): 154–61. doi:10.1055/s-2003-39778. PMID12784189.
Claes S, Villafuerte S, Forsgren T, et al. (2003). "The corticotropin-releasing hormone binding protein is associated with major depression in a population from Northern Sweden". Biol. Psychiatry. 54 (9): 867–72. doi:10.1016/S0006-3223(03)00425-6. PMID14573312.
Sehringer B, Zahradnik HP, Simon M, et al. (2005). "mRNA expression profiles for corticotrophin-releasing hormone, urocortin, CRH-binding protein and CRH receptors in human term gestational tissues determined by real-time quantitative RT-PCR". J. Mol. Endocrinol. 32 (2): 339–48. doi:10.1677/jme.0.0320339. PMID15072543.
Herringa RJ, Roseboom PH, Kalin NH (2006). "Decreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenic subjects". Neuropsychopharmacology. 31 (8): 1822–31. doi:10.1038/sj.npp.1301038. PMID16482088.